More Business Wire
View Older Stories View Newer Stories-
Mercialys: Number of Outstanding Shares and Voting Rights as of October 31, 2024
-
Lyft and Mobileye Team Up to Enable Autonomous Mobility at Scale
-
Carlsmed Launches Cutting-Edge Digital Production Line, Revolutionizing Spine Surgery
-
Ribbon Bio Appoints John Luckey as Chief Technology Officer
-
Lyft Announces New Round of Autonomous Partnerships
-
Openprise Announces the Trailblazers of 2024: Celebrating Data-Driven RevOps Innovators
-
Affini-T Therapeutics to Present Trial-in-Progress Poster and Preclinical Data from Its Oncogenic Driver Programs Targeting TP53 R175H, KRAS G12D and KRAS-G12V at the Society for Immunotherapy of Canc
-
PagerDuty Recognized as a Leader in 2024 GigaOm Radar for AIOps
-
From Rice Farming to Biochar: Greenery to Showcase Innovative, Low-Carbon Agriculture at COP29
-
ventureLAB Kicks Off Day One of its 4th Annual HardTech Summit
-
enGen and Abacus Insights Collaborate to Enhance Client Value of enGen’s Growing Suite of Industry-Leading Payer Solutions
-
Brightwood and PhenixFIN Provide Senior Secured Credit Facility and Preferred Equity Facility to Support the Refinancing of MB Precision Investment Holdings LLC
-
Flatiron Health Announces Research to be Presented at International Society for Pharmacoeconomics and Outcomes Research Europe 2024 Annual Meeting
-
Sagewind Capital Partners with Sabel Systems
-
DoubleVerify Unveils Attention Offering for Publishers, Raising the Bar for Performance Optimization and Transparency
-
Peachtree Group Expands Third-Party Hotel Management Business with New Partnership with Group 10 Management
-
Pinnacle West Reports Slightly Lower 2024 Third-Quarter Results Compared to a Year Ago
-
Half of the 2023 U.S. Pharmaceutical Launch Class Underperforms Pre-Launch First Year Forecasts but the Needle Is Moving
-
DiaMedica Therapeutics to Provide a Business Update and Report Third Quarter 2024 Financial Results November 14, 2024
-
MFA Financial, Inc. Announces Third Quarter 2024 Financial Results
-
Kopin Announces Design Win from Assisted Reality Solution Provider, Get Your Way
-
Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem
-
Hy-Vee Optimizes Supply Chain Execution and Inventory With Manhattan Solutions
-
Rand Capital Reports 27% Increase in Total Investment Income for Third Quarter 2024, Supported by Strategic Debt Portfolio Growth
-
Pagaya Raises $1 Billion Across Two New Personal Loan and Auto ABS Deals, Signaling Strong Capital Markets Demand
-
Colony Bankcorp, Inc. to Participate in 2024 Hovde Group Financial Services Conference
-
Vertical Aerospace to Share Business Update
-
Simulations Plus to Participate in the Stephens Annual Investment Conference
-
Addigy Launches One-Click CMMC and DISA STIG Benchmarks to Simplify, Accelerate Apple Device Compliance
-
Mogo Reports Results for Q3 2024 and Expects Positive Adjusted Net Income for 2025
-
CUTRIC Releases ZEB Database Report #5, Canada's Zero Emissions Bus Landscape and Transitioning Readiness, Suggesting Canada is on Track to Meet 2026 Goal
-
Stratasys H350 Now Powered by New SAF ReLife Solution Capable of Repurposing Waste PA12 Powder as Sustainable Additive Manufacturing Production Parts, at Scale
-
BlackRock TCP Capital Corp. Announces Third Quarter 2024 Financial Results
-
Genestra Launches Second Annual Gut Check Awareness Campaign
-
Indra Wins a Major Contract in the United States to Renew the Air-ground Communications System Key to the Country’s Air Traffic Management (ATM)
-
AI Proteins Selected as a Winner of the Falling Walls Venture Science Start-up Competition
-
Centuri Reports Third Quarter 2024 Results, Reiterates 2024 Guidance
-
Agilent Presents Solutions Innovation Research Awards to Institut National de la Recherche Scientifique and University of Southern California Scientists
-
Atlanta Braves Holdings Reports Third Quarter 2024 Financial Results
-
Coya Therapeutics Provides a Corporate Update and Reports Unaudited Third Quarter 2024 Financial Results
-
UroGen Pharma Reports 2024 Third Quarter Financial Results and Business Highlights, Including the Potential Launch of UGN-102 in 2025
-
Coupang Announces Pre-Arranged Stock Sale Plan by Founder
-
Helios Technologies to Participate in Upcoming Investor Conferences
-
Seismic Therapeutic Presents Data Demonstrating Key Capabilities and Broad Utility of Its Machine Learning-enabled IMPACT Platform to Create Novel Biologic Medicines
-
Carolina Biological Supply Company Announces OpenSciEd Science Units for Grades K to 5 Certified Version
-
Satisfaction with Store-Bought Mattresses Springs Back, Tying with Online Purchase Satisfaction, J.D. Power Finds
-
Ontrak Health Expands Behavioral Health Solutions with Sentara Health Plans for Commercial and Marketplace Populations
-
Innovate 32 Announces Partnership with Marion Dental Group
-
2B Associates Appoints Seasoned Executive Joshua Blair as COO to Drive Operational Excellence
-
Tiffany Salas-Morris Joins Slingshot Biosciences as Chief Commercial Officer
